VPN Plus+ Exclusive
Questions about anti-nerve growth factor drugs
December 1, 2022When the guidelines first showed up, most veterinarians couldn’t even access antiNGF mAB drugs. The feline version, frunevetmab, received Food and Drug Administration (FDA) approval on January 13, 2022, but it remained unavailable to most veterinarians well into the summer. We still do not know when, or if, the canine version will receive a green light from the FDA.